BioCentury
ARTICLE | Company News

Auric Pharma, Neuro-Biotech Corp. deal

February 21, 2011 8:00 AM UTC

Neuro-Biotech's board has accepted Auric's previously announced offer to acquire all outstanding shares of the biotech for $0.15 per share, or about $99.4 million. The price is a 400% premium to Neuro...